Correction: Cost of Anti-CD38 Monoclonal Antibodies in Combination With Bortezomib, Lenalidomide and Dexamethasone for the Frontline Treatment of Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma in the US.

ABSTRACT: [This corrects the article DOI: 10.36469/001c.141714.].

SUBMITTER: Gupta-Werner N 

PROVIDER: S-EPMC12352406 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature